Markets
Domestic private, public procurement, regional export, contract manufacture or international supply.
Manufacturing foundation hub · Africa and India
End-to-End Pharmaceutical Factory Setup Roadmap for Africa and India
Plan, design, license, validate and operate a medium-to-large pharmaceutical manufacturing facility—from investment case through reliable commercial supply.
PROJECT CONTROL MAP01Define the investment case02Fix the regulatory and technical basis03Select the site and create the concept04Design, specify and procure05Build the organization and quality system06Commission, qualify and validate07Transfer products and prove readiness08Licence, launch and sustain control
Use this hub correctly
A factory project is one connected system.
Buildings, equipment and licences are only part of the project. A successful facility must align its market, products, regulatory strategy, process design, utilities, people, quality system, laboratory, supply chain and financial model. Decisions made early determine what can be validated and sustained later.
This hub provides the control map. It is not a substitute for product-specific engineering, local legal advice, regulator engagement or approved company procedures.
Before committing capital
Fix six decisions that shape everything else.
Products
Dosage forms, therapeutic priorities, batch sizes, containment needs, stability and registration status.
Scale
Demand ranges, practical utilization, campaign strategy, changeovers, yields, downtime and expansion.
Standard
National GMP, intended export expectations, customer audits and future WHO or other qualification ambitions.
Operating model
What will be made, tested, stored or outsourced—and how external parties will be controlled.
Capital logic
Funding, foreign exchange, working capital, project contingencies, start-up losses and return thresholds.
End-to-end roadmap
Eight stage gates from concept to reliable supply.
Each gate should answer a decision with documented evidence before the project commits substantially more money, time or regulatory risk.
Stage01
Define the investment case
What should the facility make, for whom, at what scale and with what competitive advantage?
Minimum outputs
- Target markets, customers and procurement channels
- Initial product and dosage-form portfolio
- Demand, capacity and utilization scenarios
- Make, buy or contract-manufacture assessment
- Preliminary CAPEX, OPEX, working capital and funding case
- Project risks, assumptions and investment decision criteria
Gate evidence
An approved business case with a defined product scope and credible demand—not merely a decision to buy equipment.
Stage02
Fix the regulatory and technical basis
Which licences, GMP standards, products and markets will drive the design?
Minimum outputs
- Applicable national regulator and permit map
- Domestic, export and procurement-market requirements
- Product registration and dossier strategy
- Design basis covering dosage forms, containment and segregation
- Target GMP baseline and future expansion requirements
- Regulatory engagement and inspection pathway
Gate evidence
A written user and regulatory requirements basis that designers, vendors and management can all work from.
Stage03
Select the site and create the concept
Can the proposed location support safe, compliant and resilient operations?
Minimum outputs
- Site due diligence, geotechnical and environmental assessment
- Personnel, material, waste and equipment movement philosophy
- Conceptual layouts and room data requirements
- Utility demand and resilience assessment
- Expansion, containment and business-continuity provisions
- Concept estimate and integrated project schedule
Gate evidence
A concept design independently challenged for flow, contamination control, maintainability, capacity and expansion.
Stage04
Design, specify and procure
Do the designs and purchase specifications translate the intended process and GMP controls correctly?
Minimum outputs
- Approved detailed layouts, zoning and pressure cascade
- URSs for facilities, utilities, equipment and computerized systems
- Vendor prequalification and technical bid evaluations
- Design qualification and risk assessments
- Factory acceptance, delivery, installation and spares plans
- Change, document and configuration controls for the project
Gate evidence
Approved designs and suppliers supported by documented requirements, risk review and lifecycle support—not price alone.
Stage05
Build the organization and quality system
Will competent people and controlled systems be ready when the assets are ready?
Minimum outputs
- Organization structure, role profiles and recruitment plan
- Quality Manual, Site Master File and documentation hierarchy
- Core SOPs, specifications, methods and master records
- Training and qualification curricula
- Supplier, contractor and service-provider controls
- Quality risk, data governance and management-review systems
Gate evidence
The operational team owns usable systems and records before routine manufacturing begins.
Stage06
Commission, qualify and validate
Can objective evidence show that facilities, utilities, equipment, methods and processes are fit for intended use?
Minimum outputs
- Commissioning plan and turnover packages
- Qualification strategy, protocols, reports and traceability
- Calibration, maintenance and spare-parts systems
- Cleaning, process, analytical and computerized-system validation
- Environmental, water and utility monitoring programmes
- Deviations, punch lists and controlled acceptance decisions
Gate evidence
Critical requirements are traceable to approved evidence, unresolved items are risk-assessed and the validated state can be maintained.
Stage07
Transfer products and prove readiness
Can the receiving site reproducibly manufacture, test, release and supply each product?
Minimum outputs
- Technology-transfer and analytical-transfer plans
- Master formulae, batch records and packaging instructions
- Material, artwork and supplier readiness
- Engineering, exhibit or registration batches as applicable
- Process performance qualification and stability commitments
- Integrated operational-readiness and data-review exercises
Gate evidence
Product knowledge, methods, materials, records, trained people and supply arrangements are ready as one system.
Stage08
Licence, launch and sustain control
Is the site ready for inspection, commercial release and continued reliable supply?
Minimum outputs
- GMP and manufacturing-licence application package
- Inspection-readiness room, records and response process
- Approved products, supply commitments and launch controls
- Deviation, CAPA, complaint, recall and change processes
- PQR/APR, continued verification and quality metrics
- Management review, internal audit and improvement programme
Gate evidence
Regulatory authorization and internal Quality approval are supported by sustained evidence—not a one-time inspection exercise.
Cross-functional control
Run twelve workstreams on one integrated plan.
No department can declare the facility ready by itself. Dependencies, decisions and evidence must be visible across the project.
Business and capital
Demand, portfolio, capacity, CAPEX, OPEX, cash flow, funding, insurance and commercial milestones.
Regulatory and licensing
Facility licences, product pathways, permits, inspections, registrations, variations and market commitments.
Facility and flows
Site plan, zoning, rooms, people and material movement, containment, finishes, cleaning and expansion.
Utilities and resilience
HVAC, water, power, steam, compressed air, drainage, monitoring, redundancy and business continuity.
Equipment and automation
URS, selection, capacity, controls, data, qualification, maintenance, spares and lifecycle support.
Quality systems
Governance, documents, risk, training, events, CAPA, change, audit, suppliers, complaints and review.
Production and packaging
Process design, master records, in-process controls, yields, cleaning, line clearance and reconciliation.
QC and microbiology
Laboratory design, methods, instruments, reference standards, stability, microbiology and sample flows.
Qualification and validation
VMP, DQ/IQ/OQ/PQ, cleaning, process, methods, computerized systems and continued verification.
Materials and supply chain
Approved suppliers, imports, warehousing, status control, FEFO, cold chain, distribution and returns.
People, EHS and security
Staffing, competence, hygiene, occupational health, waste, emergency response and site security.
Digital and performance
ERP/LIMS/QMS choices, data governance, cyber controls, KPIs, OEE, costing and management reporting.
QMS documentation centre
Build the document hierarchy alongside the facility.
Documentation should grow from process knowledge and approved controls. It should not be a late collection of generic SOPs prepared only for inspection.
Governance
Quality Manual, Site Master File, policies, VMP, quality objectives and management-review framework.
System procedures
Documents, training, risk, deviations, CAPA, change, OOS, audit, complaints, recall and suppliers.
Operational control
Master formulae, batch records, specifications, methods, protocols, work instructions and maintenance plans.
Objective evidence
Forms, registers, logbooks, checklists, raw data, reports, trends and management decisions.
Africa and India context
Use one quality logic—but never assume one legal pathway.
Common GMP baseline
Begin with the current requirements of the competent national authority and the approved product strategy. Use WHO GMP and ICH quality principles to connect facility design, pharmaceutical development, risk, validation and lifecycle management.
- Patient and product risk
- Documented intended use
- Lifecycle evidence
- Management responsibility
African implementation
Africa is not one regulatory jurisdiction. Map the national authority, regional pathways and target procurement or export markets separately, then design for local execution realities.
- Power, water and service resilience
- Import lead times and foreign exchange
- Technical skills and vendor support
- National and regional market access
Indian implementation
Map central, state and local responsibilities, including drug-manufacturing, factory, environmental, fire and building permissions. Align the facility and quality system with the current Schedule M and intended export markets.
- Central and State licensing roles
- Revised Schedule M readiness
- Pollution and factory approvals
- Domestic versus export standards
Expensive failure patterns
Find design mistakes while they are still cheap to correct.
| Failure pattern | What goes wrong | Better project control |
|---|---|---|
| Equipment-led planning | A vendor quotation becomes the project design before products, processes, flows and utilities are defined. | Approve the product, process and user-requirements basis first. |
| Capacity without demand logic | Nameplate output is mistaken for saleable capacity and working capital, changeovers and downtime are ignored. | Model demand, batch sizes, OEE, campaigns, yields and cash conversion together. |
| Quality added late | QA is asked to write SOPs after construction and equipment decisions are already fixed. | Embed Quality, validation, QC and operations in design reviews from the start. |
| Utilities treated as support services | Water, HVAC, power quality or compressed air becomes the constraint after equipment arrives. | Base utility capacity and redundancy on process demand, qualification and growth scenarios. |
| Qualification becomes document production | Protocols are executed without a clear link to intended use, risks and acceptance criteria. | Maintain traceability from URS and risk controls to commissioning and qualification evidence. |
| Licence and product strategy diverge | The facility is designed for products or markets that require additional segregation, data or inspection standards. | Freeze the regulatory design basis early and control subsequent changes. |
| Operational readiness is fragmented | Engineering, QA, QC, production and supply chain declare readiness separately. | Use one integrated readiness review covering people, assets, materials, systems and records. |
Practical starting sequence
The first 90 days should reduce uncertainty—not order machinery.
Write the project brief
Define target markets, dosage forms, provisional products, annual demand, capacity logic, strategic advantage and non-negotiable constraints.
Map regulation and permits
Confirm licensing authorities, product pathways, site permissions, environmental requirements, inspection expectations and early regulator engagement.
Create the design basis
Document process steps, batch sizes, containment, flows, room needs, utilities, laboratory scope, warehouse capacity and future expansion.
Test sites and concepts
Compare locations and conceptual layouts against logistics, infrastructure, people, utilities, environmental risk, maintainability and total cost.
Make the first gate decision
Approve the project charter, governance, concept, budget range, schedule, risk register and the evidence required before detailed design.
Primary framework references
Accessed 20 October 2026. Always confirm the current legal requirements, approved product commitments and competent authority expectations for the proposed site and markets.
- World Health Organization: Good Manufacturing Practice standards
- WHO TRS 986, Annex 2: GMP for pharmaceutical products—main principles
- ICH Quality Guidelines, including Q8, Q9, Q10 and Q12
- PIC/S publications and current GMP Guide
- European Commission: EudraLex Volume 4 GMP guidance
- Central Drugs Standard Control Organisation, India
- African Union: Pharmaceutical Manufacturing Plan for Africa—Business Plan
Educational notice: This roadmap provides general education and project-structuring guidance. Facility design, validation, licensing and product decisions require qualified specialists and formal approval under the applicable regulatory and company systems.